Navigation Links
Generex Schedules Press Conference & Investor Call for March 30th to Discuss Management's Strategic Development Plan for Future Growth
Date:3/22/2011

WORCESTER, Mass., March 22, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTC Bulletin Board: GNBT) announced today that Company management will conduct a press conference and investor call on March 30, 2011 to discuss its strategic development plan for the Company's future growth.  

(Logo: https://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b)

Soon after his appointment as Interim President & Chief Executive Officer, Mark Fletcher and the Generex management team began conducting an in-depth review of the Company's operations and scientific initiatives in an effort to further the development of Generex Oral-lyn™, the Company's proprietary buccal insulin spray product, and the Antigen Express AE37 immunotherapeutic cancer vaccine platform, streamline operations, and maximize the value of the substantial intellectual properties currently held by the Company.  After completing that review, management has developed a strategic plan to further the Company's science with a view to creating the greatest likelihood for commercial successes as well as attain the highest possible long-term value for Generex and its stockholders.  

Management will discuss this plan along with the current status of its various drug development initiatives on March 30, 2011 at a press conference in New York City and an investor call.  The details for attending the press conference and participation in the investor call via webcast or telephonically will be provided in the very near future.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies.  Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015  Michigan brothers Dominique Larkin , 23, ... right ventricular dysplasia, or ARVD, a disease that causes irregular ... among young athletes. In 2007, doctors discovered the ... They later tested Dominique and found his "condition was just ... 2015 story in The Ann Arbor News , part ...
(Date:3/3/2015)... 2015 Research and Markets ( ... "Global Ultrasound Equipment Market 2015-2019" report ... The Global Ultrasound Equipment market to grow at ... Ultrasound equipment are used to examine ... extensively used by cardiologists, radiologists, surgeons, obstetricians, and ...
(Date:3/3/2015)...   VWR  (NASDAQ:  VWR), a leading, independent ... today the expansion of its distribution agreement with ... VWR increased access to NEB,s growing product portfolio ... Puerto Rico.  In addition, customers will now have ... sales organization, and VWRCATALYST, our onsite services organization. ...
Breaking Medicine Technology:Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2VWR Announces Expansion of Distribution Agreement with New England Biolabs 2
... and Reaffirms its 2010 Guidance -- XI,AN, China, Aug. 23 /PRNewswire-Asia-FirstCall/ -- ... ... ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
... ALTO, Calif., Aug. 20 Jazz Pharmaceuticals, Inc. (Nasdaq: ... Advisory Committee of the U.S. Food and Drug Administration ... Safety and Risk Management Advisory Committee, voted 20-2 that ... JZP-6 for the treatment of fibromyalgia with the currently ...
Cached Medicine Technology:Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 2Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 3Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 4Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 5Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 6Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 7Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 8Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance 9Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia 2
(Date:3/3/2015)... March 03, 2015 Longtime parent visionary ... CARE Surrogacy Center for a candid interview ... appearing online is an exhilarating revelation of his magical ... led him from Australia to the birth of his ... interchange, Tolga Umar, CEO and Founder of CARE stated, ...
(Date:3/3/2015)... 03, 2015 Dan E. Chambers, an experienced ... focus on capital crimes, recently spoke on the radio to ... The hosts of the Independent Journal Review radio show “The ... first as a prosecutor and now as a criminal defense ... made in the trial and sentencing of this high-profile case. ...
(Date:3/3/2015)... The report “Alopecia – Pipeline Review, H1 2015? ... Alopecia is the loss of hair. Alopecia areata and ... Causes for alopecia include aging, genetics, illness, chemotherapy, malnutrition ... pattern hair loss, female diffuse hair loss, hairs easily ... focal or diffuse and by the presence or absence ...
(Date:3/3/2015)... The first week of March is ... The event brings recognition to a rarely discussed problem ... According to the Centers for Disease Control , 70 ... or another. Too little or unrestful sleep is associated ... and depression, and even a higher likelihood of obesity. ...
(Date:3/3/2015)... The combinatorial, multi-gene GeneSight test ... outcomes for patients with depression, and their use ... individual genes that comprise the test, according to ... Clinic and Assurex Health, and published online by ... technology of the GeneSight Psychotropic test is based ...
Breaking Medicine News(10 mins):Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6
... Alseres,Pharmaceuticals, Inc. (Nasdaq: ALSE ) today ... Restated Convertible Promissory Note Purchase Agreement,dated as of ... Gipson, Arthur,Koenig, Ingalls & Snyder Value Partners, L.P. ... provides for the Company to borrow,in addition to ...
... a major study to track global funding for research ... by surveying global public, private and philanthropic investments. As ... do not have a complete overview of how much ... makes determining funding gaps difficult. The George Institute for ...
... Va., March 20 Sunrise Senior Living,Inc. (NYSE: ... Ordan as Chief,Investment and Administrative Officer, effective March 19, ... the Chief Executive Officer and,a Director of The Mills ... to Simon Property Group and Farallon in May 2007. ...
... DHR ) announced today that its quarterly earnings conference ... April 17, 2008 beginning,at 8:00 a.m. EDT and lasting ... Danaher,s website at http://www.danaher.com with,an accompanying slide ... for the 2008 first,quarter will be available prior to ...
... Model - Certified asthma & allergy friendly(TM) by the Asthma, and ... ... to More Consumers, ENGLEWOOD CLIFFS, N.J., March ... season. To help those suffering from,common household allergies, LG Electronics today ...
... Next Steps in $128 Million Contract -, GAITHERSBURG, ... today announced positive interim results from the,500-subject Phase 1/2 ... vaccine for H5N1 influenza. The trial met a key ... patch,was used with a single dose of the 45-microgram ...
Cached Medicine News:Health News:Alseres Pharmaceuticals, Inc. Raises $5 Million 2Health News:Alseres Pharmaceuticals, Inc. Raises $5 Million 3Health News:George Institute receives Gates Foundation grant to survey funding flows 2Health News:Sunrise Senior Living Names Mark Ordan Chief Investment and Administrative Officer 2Health News:Sunrise Senior Living Names Mark Ordan Chief Investment and Administrative Officer 3Health News:LG Electronics Debuts Unique Allergen-Reducing Steam Washer/Dryer Combo 2Health News:LG Electronics Debuts Unique Allergen-Reducing Steam Washer/Dryer Combo 3Health News:LG Electronics Debuts Unique Allergen-Reducing Steam Washer/Dryer Combo 4Health News:Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels 2Health News:Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels 3Health News:Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels 4Health News:Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: